ClinicalTrials.gov
public full text
Public Domain
Prevalence of Hyperprolactinemia in Systemic Scleroderma
Systemic sclerosis is an autoimmune and inflammatory disease characterized primarily by fibrosis and vascular involvement. We know that the immune system is disrupted in systemic sclerosis, but there are probably other mechanisms to explain the disease, including deregulation of certain proteins such as prolactin
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- SAT0447 Correlations Between Blood Perfusion and Dermal Thickness in Different Skin Areas of Systemic Sclerosis Patients#304780
- A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus#448828
- BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA#825713
- Environmental and occupational factors in the aetiopathogenesis of systemic sclerosis: insights from a large multinational patient survey#185358
- Environmental and occupational factors in the aetiopathogenesis of systemic sclerosis: insights from a large multinational patient survey#144997
Record · ID 834058
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive